Oncologix Tech Inc

DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price

Alpharidge Capital announces “Custodianship Updates”: live Shareholder Conference Call slated for Monday, October 18th, 2021 on Zoom

ONCOLOGIX TECH, INC. ANNOUNCES RELEASE OF UNAUDITED FINANCIAL RESULTS

ONCOLOGIX TECH, INC. ANNOUNCES INCREASE IN TOTAL NUMBER OF SHARES OF AUTHORIZED COMMON STOCK

Oncologix Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations